Clinical applications of platelet antibody and antigen testing

Laboratory Medicine

Volumn 42, Issue 11, 2011, Pages 687-692

  Lochowicz, Andrew J ^a   Curtis, Brian R ^a  

^a BLOOD RESEARCH INSTITUTE   (United States)

Author keywords

Flow cytometry; Genotyping; Immune thrombocytopenia; ITP; Neonatal alloimmune thrombocytopenia; Platelet antibody

Indexed keywords

ALLOANTIBODY; ALLOANTIGEN; FIBRINOGEN RECEPTOR; GLYCOPROTEIN IB; HUMAN PLATELET ALLOANTIGEN 1; HUMAN PLATELET ALLOANTIGEN 10; HUMAN PLATELET ALLOANTIGEN 11; HUMAN PLATELET ALLOANTIGEN 12; HUMAN PLATELET ALLOANTIGEN 13; HUMAN PLATELET ALLOANTIGEN 14; HUMAN PLATELET ALLOANTIGEN 15; HUMAN PLATELET ALLOANTIGEN 16; HUMAN PLATELET ALLOANTIGEN 17; HUMAN PLATELET ALLOANTIGEN 18; HUMAN PLATELET ALLOANTIGEN 19; HUMAN PLATELET ALLOANTIGEN 2; HUMAN PLATELET ALLOANTIGEN 20; HUMAN PLATELET ALLOANTIGEN 21; HUMAN PLATELET ALLOANTIGEN 3; HUMAN PLATELET ALLOANTIGEN 4; HUMAN PLATELET ALLOANTIGEN 5; HUMAN PLATELET ALLOANTIGEN 6; HUMAN PLATELET ALLOANTIGEN 7; HUMAN PLATELET ALLOANTIGEN 8; HUMAN PLATELET ALLOANTIGEN 9; IMMUNOGLOBULIN; PREDNISONE; STEROID; THROMBOCYTE ANTIBODY; THROMBOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIGEN CAPTURE ENZYME LINKED IMMUNOSORBENT ASSAY; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE THROMBOCYTOPENIA; BRAIN HEMORRHAGE; CASE REPORT; CONTROLLED STUDY; DRUG INDUCED DISEASE; DRUG INDUCED IMMUNE THROMBOCYTOPENIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENOTYPE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNE THROMBOCYTOPENIA; IMMUNOASSAY; IMMUNOFLUORESCENCE; IMMUNOPATHOLOGY; MODIFIED ANTIGEN CAPTURE ENZYME LINKED IMMUNOSORBENT ASSAY; MONOCLONAL ANTIBODY IMMOBILIZATION OF PLATELET ANTIGEN; NEONATAL ALLOIMMUNE THROMBOCYTOPENIA; NEWBORN; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

EID: 84855563797     PISSN: 00075027     EISSN: 19437730     Source Type: Journal    
DOI: 10.1309/LMM242GKGHCKJRWI     Document Type: Article

References (31)

1. Neunert C, Lim W, Crowther M, et al. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 2011;117:4190-4207.
2. Aster RH, Curtis BR, Bougie DW, et al. Thrombocytopenia associated with the use of GPIIb/IIIa inhibitors: Position paper of the ISTH working group on thrombocytopenia and GPIIb/IIIa inhibitors. J Thromb Haemost. 2006;4:678-679.
3. Aster RH, Curtis BR, McFarland JG. Drug-induced immune thrombocytopenia: Pathogenesis, diagnosis, and management. J Thromb Haemost. 2009;7:911-918.
4. Reese JA, Li X, Hauben M, et al. Identifying drugs that cause acute thrombocytopenia: An analysis using 3 distinct methods. Blood. 2010;116:2127-2133.
5. Murphy MF, Bussel JB. Advances in the management of alloimmune thrombocytopenia. Br J Haematol. 2007;136: 366-378.
6. Kaplan C. Immune thrombocytopenia in the fetus and neonate: Diagnosis and therapy. Thromb Res. 2005;115(Suppl 1):39-41.
7. McFarland JG. Post-transfusion purpura. In: Popovsky MA, ed. Transfusion Reactions. Bethesda: AABB Press; 2006.
8. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. The Trial to Reduce Alloimmunization to Platelets Study Group. N Engl J Med. 1997;337:1861-1869.
9. Curtis BR, McFarland JG. Platelet immunology and alloimmunization. In: Simon TL, Dzik WH, Snyder EL, et al., eds. Rossi's Principles of Transfusion Medicine. Philadelphia, PA: Lippincott Williams and Wilkins; 2008: 203-217.
10. George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996;88:3-40.
11. McMillan R, Tani P, Millard F, et al. Platelet-associated and plasma anti-glycoprotein autoantibodies in chronic ITP. Blood. 1987;70:1040-1045.
12. Davoren A, Bussel J, Curtis BR, et al. Prospective evaluation of a new platelet glycoprotein (GP)-specific assay (PakAuto) in the diagnosis of autoimmune thrombocytopenia (AITP). Am J Hematol. 2005;78:193-197.
13. Aster RH, Bougie DW. Drug-induced immune thrombocytopenia. N Engl J Med. 2007;357:580-587.
14. Von Drygalski A, Curtis BR, Bougie DW, et al. Vancomycin-induced immune thrombocytopenia. N Engl J Med. 2007;356:904-910.
15. Curtis BR, McFarland JG, Wu GG, et al. Antibodies in sulfonamide-induced immune thrombocytopenia recognize calcium-dependent epitopes on the glycoprotein IIb/IIIa complex. Blood. 1994;84:176-183.
16. Visentin GP, Wolfmeyer K, Newman PJ, et al. Detection of drug-dependent, platelet-reactive antibodies by antigen-capture ELISA and flow cytometry. Transfusion. 1990;30:694-700.
17. Wu GG, Kaplan C, Curtis BR, et al. Report on the 14th International Society of Blood Transfusion Platelet Immunology Workshop. Vox Sang. 2010;99:375-381.
18. Goldman M, Trudel E, Richard L. Report on the Eleventh International Society of Blood Transfusion Platelet Genotyping and Serology Workshop. Vox Sang. 2003;85:149-155.
19. Kiefel V, Santoso S, Weisheit M, et al. Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): A new tool for the identification of platelet-reactive antibodies. Blood. 1987;70:1722-1726.
20. Hessner MJ, Curtis BR. Prenatal genotyping for identification of fetuses at risk for immune cytopenic disorders. In: Coleman WB, Tsongalis GJ, eds. Molecular Diagnostics for the Clinical Laboratorian. Totowa, NJ: Humana Press; 2006.
21. Davoren A, Curtis BR, Aster RH, et al. Human platelet antigen-specific alloantibodies implicated in 1162 cases of neonatal alloimmune thrombocytopenia. Transfusion. 2004;44:1220-1225.
22. Curtis BR, McFarland JG. Detection and identification of platelet antibodies and antigens in the clinical laboratory. Immunohematology. 2009;25:125-135.
23. Christopoulos CG, Kelsey HC, Machin SJ. A flow-cytometric approach to quantitative estimation of platelet surface immunoglobulin G. Vox Sang. 1993;64:106-115.
24. Hézard N, Simon G, Macé C, et al. Is flow cytometry accurate enough to screen platelet autoantibodies? Transfusion. 2008;48:513-518.
25. Furihata K, Nugent DJ, Bissonette A, et al. On the association of the platelet-specific alloantigen, Pena, with glycoprotein IIIa. Evidence for heterogeneity of glycoprotein IIIa. J Clin Invest. 1987;80:1624-1630.
26. Menitove JE, Pereira J, Hoffman R, et al. Cyclic thrombocytopenia of apparent autoimmune etiology. Blood. 1989;73:1561-1569.
27. Kakaiya RM, Triulzi DJ, Wright DJ, et al. Prevalence of HLA antibodies in remotely transfused or alloexposed volunteer blood donors. Transfusion. 2010;50:1328-1334.
28. Triulzi DJ, Kleinman S, Kakaiya RM, et al. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: Implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion. 2009;49:1825-1835.
29. Hurd CM, Cavanagh G, Schuh A, et al. Genotyping for platelet-specific antigens: Techniques for the detection of single nucleotide polymorphisms. Vox Sang. 2002;83:1-12.
30. Curtis BR. Genotyping for human platelet alloantigen polymorphisms: Applications in the diagnosis of alloimmune platelet disorders. Semin Thromb Hemost. 2008;34:539-548.
31. Berkowitz RL, Bussel JB, McFarland JG. Alloimmune thrombocytopenia: State of the art 2006. Am J Obstet Gynecol. 2006;195:907-913.